These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 34774918)

  • 21. Optimization of formulation and atomization of lipid nanoparticles for the inhalation of mRNA.
    Miao H; Huang K; Li Y; Li R; Zhou X; Shi J; Tong Z; Sun Z; Yu A
    Int J Pharm; 2023 Jun; 640():123050. PubMed ID: 37201764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating how cationic lipid affects mRNA-LNP physical properties and biodistribution.
    Guéguen C; Ben Chimol T; Briand M; Renaud K; Seiler M; Ziesel M; Erbacher P; Hellal M
    Eur J Pharm Biopharm; 2024 Feb; 195():114077. PubMed ID: 37579889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of macromolecular structure evolution in self-assembled lipid nanoparticles for siRNA delivery.
    Gindy ME; DiFelice K; Kumar V; Prud'homme RK; Celano R; Haas RM; Smith JS; Boardman D
    Langmuir; 2014 Apr; 30(16):4613-22. PubMed ID: 24684657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesoscopic Structure of Lipid Nanoparticle Formulations for mRNA Drug Delivery: Comirnaty and Drug-Free Dispersions.
    Unruh T; Götz K; Vogel C; Fröhlich E; Scheurer A; Porcar L; Steiniger F
    ACS Nano; 2024 Apr; 18(13):9746-9764. PubMed ID: 38514237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid shape and packing are key for optimal design of pH-sensitive mRNA lipid nanoparticles.
    Tesei G; Hsiao YW; Dabkowska A; Grönberg G; Yanez Arteta M; Ulkoski D; Bray DJ; Trulsson M; Ulander J; Lund M; Lindfors L
    Proc Natl Acad Sci U S A; 2024 Jan; 121(2):e2311700120. PubMed ID: 38175863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acidic pH-induced changes in lipid nanoparticle membrane packing.
    Koitabashi K; Nagumo H; Nakao M; Machida T; Yoshida K; Sakai-Kato K
    Biochim Biophys Acta Biomembr; 2021 Aug; 1863(8):183627. PubMed ID: 33901441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. pH-Dependent Lyotropic Liquid Crystalline Mesophase and Ionization Behavior of Phytantriol-Based Ionizable Lipid Nanoparticles.
    Yu H; Dyett B; Kirby N; Cai X; Mohamad ME; Bozinovski S; Drummond CJ; Zhai J
    Small; 2024 May; 20(20):e2309200. PubMed ID: 38295089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insights into the Structure of Comirnaty Covid-19 Vaccine: A Theory on Soft, Partially Bilayer-Covered Nanoparticles with Hydrogen Bond-Stabilized mRNA-Lipid Complexes.
    Szebeni J; Kiss B; Bozó T; Turjeman K; Levi-Kalisman Y; Barenholz Y; Kellermayer M
    ACS Nano; 2023 Jul; 17(14):13147-13157. PubMed ID: 37417667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Why mRNA-ionizable LNPs formulations are so short-lived: causes and way-out.
    De A; Ko YT
    Expert Opin Drug Deliv; 2023 Feb; 20(2):175-187. PubMed ID: 36588456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ready-to-Use-Type Lyophilized Lipid Nanoparticle Formulation for the Postencapsulation of Messenger RNA.
    Tanaka H; Hagiwara S; Shirane D; Yamakawa T; Sato Y; Matsumoto C; Ishizaki K; Hishinuma M; Chida K; Sasaki K; Yonemochi E; Ueda K; Higashi K; Moribe K; Tadokoro T; Maenaka K; Taneichi S; Nakai Y; Tange K; Sakurai Y; Akita H
    ACS Nano; 2023 Feb; 17(3):2588-2601. PubMed ID: 36719091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A lipid nanoparticle platform for mRNA delivery through repurposing of cationic amphiphilic drugs.
    Bogaert B; Sauvage F; Guagliardo R; Muntean C; Nguyen VP; Pottie E; Wels M; Minnaert AK; De Rycke R; Yang Q; Peer D; Sanders N; Remaut K; Paulus YM; Stove C; De Smedt SC; Raemdonck K
    J Control Release; 2022 Oct; 350():256-270. PubMed ID: 35963467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PEG-OligoRNA Hybridization of mRNA for Developing Sterically Stable Lipid Nanoparticles toward In Vivo Administration.
    Kurimoto S; Yoshinaga N; Igarashi K; Matsumoto Y; Cabral H; Uchida S
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30987102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the Formation and Morphology of Lipid Nanoparticles Containing Ionizable Cationic Lipids and siRNA.
    Kulkarni JA; Darjuan MM; Mercer JE; Chen S; van der Meel R; Thewalt JL; Tam YYC; Cullis PR
    ACS Nano; 2018 May; 12(5):4787-4795. PubMed ID: 29614232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of an imaged capillary isoelectric focusing method for characterizing the surface charge of mRNA lipid nanoparticle vaccines.
    Loughney JW; Minsker K; Ha S; Rustandi RR
    Electrophoresis; 2019 Sep; 40(18-19):2602-2609. PubMed ID: 31218707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid nanoparticles containing labile PEG-lipids transfect primary human skin cells more efficiently in the presence of apoE.
    Gregersen CH; Mearraoui R; Søgaard PP; Clergeaud G; Petersson K; Urquhart AJ; Simonsen JB
    Eur J Pharm Biopharm; 2024 Apr; 197():114219. PubMed ID: 38368913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo evaluation of clinically-approved ionizable cationic lipids shows divergent results between mRNA transfection and vaccine efficacy.
    Escalona-Rayo O; Zeng Y; Knol RA; Kock TJF; Aschmann D; Slütter B; Kros A
    Biomed Pharmacother; 2023 Sep; 165():115065. PubMed ID: 37406506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coarse-Grained Simulation of mRNA-Loaded Lipid Nanoparticle Self-Assembly.
    Grzetic DJ; Hamilton NB; Shelley JC
    Mol Pharm; 2024 Sep; 21(9):4747-4753. PubMed ID: 39145436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increasing the siRNA knockdown efficiency of lipid nanoparticles by morphological transformation with the use of dihydrosphingomyelin as a helper lipid.
    Hashimoto M; Yonezawa S; Furan S; Nitta C; Maeda N; Tomita K; Yokouchi A; Koide H; Asai T
    Biomater Sci; 2023 May; 11(9):3269-3277. PubMed ID: 36939181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mixing lipids to manipulate the ionization status of lipid nanoparticles for specific tissue targeting.
    Shobaki N; Sato Y; Harashima H
    Int J Nanomedicine; 2018; 13():8395-8410. PubMed ID: 30587967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Achieving long-term stability of lipid nanoparticles: examining the effect of pH, temperature, and lyophilization.
    Ball RL; Bajaj P; Whitehead KA
    Int J Nanomedicine; 2017; 12():305-315. PubMed ID: 28115848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.